45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Roohi Ismail-Khan, MD

Assistant Professor
H. Lee Moffitt Cancer Center
12902 Magnolia Dr
Tampa, FL
USA 33612

Papers:
146 - Poster Session A The BCL2 antagonist of cell death (BAD) signaling pathway and phospho-BAD protein levels are associated with triple-negative breast cancer clinical development and clinical outcome